{"brief_title": "Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients", "brief_summary": "The purpose of this pilot study is to examine the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among methadone maintenance therapy patients.", "detailed_description": "This is a one-arm, open label pilot study of MMT patients to determine whether bupropion, nicotine replacement therapy, and behavioral counseling is a feasible and potentially effective intervention for smoking cessation. The smoking behaviors of participants will be be followed for 6 months post quit-date to determine effect-size estimates for a future, large scale trial.", "condition": "Tobacco Use Disorder", "intervention_type": "Other", "intervention_name": "Combined intervention", "description": "300 mg bupropion plus 4mg nicotine gum ad lib plus motivational interviewing counseling", "arm_group_label": "Combined Pharmacotherapy and Counseling", "criteria": "Inclusion Criteria: - Patients in long-term methadone maintenance treatment - Patient smokes at least 10 cigarettes per day, are stable on their use of methadone (phase 2 or higher treatment), smoked for at least 1 year, be willing to participate for 6 months, and not have used bupropion or nicotine replacement therapy for 6 months Exclusion Criteria: - Patients who use prescription drug regimens that might affect methadone or bupropion metabolism - Patients with cardiovascular disease, asthma, COPD - Patients who are pregnant or breastfeeding - Patients with regular use of alcohol, other illicit drugs, or other types of tobacco (chewing or pipe for example)", "gender": "All", "minimum_age": "18 Years", "maximum_age": "70 Years", "healthy_volunteers": "No", "id": "NCT00060814.xml"}